GB860888A - Soya phosphatides and therapeutic compositions containing them - Google Patents

Soya phosphatides and therapeutic compositions containing them

Info

Publication number
GB860888A
GB860888A GB7956/57A GB795657A GB860888A GB 860888 A GB860888 A GB 860888A GB 7956/57 A GB7956/57 A GB 7956/57A GB 795657 A GB795657 A GB 795657A GB 860888 A GB860888 A GB 860888A
Authority
GB
United Kingdom
Prior art keywords
soya
soya phosphatide
fraction
aluminium oxide
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7956/57A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB860888A publication Critical patent/GB860888A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • C07F9/103Extraction or purification by physical or chemical treatment of natural phosphatides; Preparation of compositions containing phosphatides of unknown structure
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00Phosphatide compositions for foodstuffs, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A stable soya phosphatide fraction which does not depress blood pressure when injected into an sthetized cats and which is a satisfactory emulsifier for the oil used in a therapeutic fat product (see Group VI) is obtained by adsorbing the undesirable reactive materials present in a solution of a soya phosphatide fraction, obtained by extracting soya phosphatides with a monohydric lower molecular weight saturated aliphatic alcohol of 1 to 8 carbon atoms and of 85 to 100% concentration, by contacting said solution with an adsorbent selected from aluminium oxide, magnesium oxide or activated carbon, and then recovering the stable soya phosphatide fraction. Ethanol is the preferred monohydric alcohol but methanol, propanol and isopropanol or mixtures thereof are also specified. In a preferred embodiment a suitable product is obtained by stirring one part by weight of the ethanol soluble portion of soya phosphatide in about ten parts by volume of ethanol with about 2 parts by weight of aluminium oxide at room temperature, filtering off the aluminium oxide and then removing the alcohol under reduced pressure. When, however, the amount of aluminium oxide is reduced to 1.5 parts by weight, the product obtained is unsatisfactory. The activated carbon used as adsorbent should be a non-acid carbon. In another embodiment a commercial solid soya phosphatide mixture having a lower oil content than commercial lecithins is extracted three times with absolute ethanol at room temperature, the extracts are clarified by gravity filtration and then concentrated under reduced pressure and put on a column of aluminium oxide which is then eluted with 95% aqueous ethanol to yield an eluate fraction from which a suitable phosphatide fraction is recovered as residue after removing the alcohol under reduced pressure. It is stated that in the stable soya phosphatide product the proportion of lecithin has been increased while the proportion of cephalin components, especially the inositol, has been reduced.ALSO:A therapeutic fat product suitable for intravenous use in human beings comprises a metabolizable non-toxic fixed oil emulsified in an aqueous vehicle by a stable soya phosphatide fraction which does not depress blood pressure when injected into an sthetized cats and which is obtainable by adsorbing the undesirable reactive materials present in a solution of a soya phosphatide fraction, obtained by extracting soya phosphatides with a monohydric lower molecular weight saturated aliphatic alcohol of 1 to 8 carbon atoms, preferably ethanol, and of 85 to 100% concentration, by contacting said solution with an adsorbent selected from aluminium oxide, magnesium oxide or activated carbon, and then recovering the stable soya phosphatide fraction (see Group IV (b)). Isotonic agents, e.g. metabolizable sugars such as glucose and fructose or polyhydroxy alcohols, e.g. sorbitol, and an antioxidant, especially a metabolizable antioxidant of the phenolic type, e.g. a combination of tertiary butyl-4-hydroxy anisole, propyl gallate and citric acid may also be added and an ethylene oxide-polypropylene glycol condensation product in which the propylene units are located in non-terminal positions and are connected to each other in a chain may be added as co-emulsifier. Suitable fixed oils are naturally occurring vegetable and animal oils, and synthetic oils, cottonseed oil and olive oil being preferred.
GB7956/57A 1956-04-30 1957-03-11 Soya phosphatides and therapeutic compositions containing them Expired GB860888A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US361088XA 1956-04-30 1956-04-30

Publications (1)

Publication Number Publication Date
GB860888A true GB860888A (en) 1961-02-15

Family

ID=21886661

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7956/57A Expired GB860888A (en) 1956-04-30 1957-03-11 Soya phosphatides and therapeutic compositions containing them

Country Status (3)

Country Link
CH (1) CH361088A (en)
DE (1) DE1177772B (en)
GB (1) GB860888A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103254227A (en) * 2013-05-08 2013-08-21 浙江大学 Method for extracting and separating phosphatidylcholine by use of phenol extraction agent

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718797C3 (en) * 1977-04-27 1987-06-19 A. Nattermann & Cie GmbH, 5000 Köln Process for the production of flowable oil-containing purified phosphatidylcholine
DE3047048A1 (en) * 1980-12-13 1982-07-29 A. Nattermann & Cie GmbH, 5000 Köln METHOD FOR SEPARATING OIL AND / OR PHOSPHATIDYLETHANOLAMINE FROM THESE ALCOHOL-SOLUBLE PHOSPHATIDYLCHOLINE PRODUCTS CONTAINING IT
DE3047011A1 (en) * 1980-12-13 1982-07-22 A. Nattermann & Cie GmbH, 5000 Köln METHOD FOR SEPARATING OIL AND / OR PHOSPHATIDYLETHANOLAMINE FROM THESE ALCOHOL-SOLUBLE PHOSPHATIDYLCHOLINE PRODUCTS CONTAINING IT
DE3047012A1 (en) * 1980-12-13 1982-07-22 A. Nattermann & Cie GmbH, 5000 Köln METHOD FOR SEPARATING ACYLATED PHOSPHOLIPID FROM THESE CONTAINING PHOSPHATIDYLCHOLINE PRODUCTS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE617508C (en) * 1932-06-22 1935-08-20 I G Farbenindustrie Akt Ges Process for the production of pure lecithin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103254227A (en) * 2013-05-08 2013-08-21 浙江大学 Method for extracting and separating phosphatidylcholine by use of phenol extraction agent
CN103254227B (en) * 2013-05-08 2016-06-08 浙江大学 A kind of method adopting phenols extraction agent extracting and separating phosphatidylcholine

Also Published As

Publication number Publication date
CH361088A (en) 1962-03-31
DE1177772B (en) 1964-09-10

Similar Documents

Publication Publication Date Title
GB1361798A (en) Soybean fractionation by solvent extraction
Sambasivarao et al. Lipid components of gangliosides
CA2040816A1 (en) Labiatae derived antioxidants and a process for extracting antioxidants from labiatae herbs
GB1508400A (en) Solvent extraction of oleaginous seed materials
JPS5791932A (en) Polyprenyl compound
GB860888A (en) Soya phosphatides and therapeutic compositions containing them
US3544605A (en) Process for obtaining highly purified phosphatidylcholine and the product of this process
JPH0796498B2 (en) How to extract the fruits of Selenoa repens
SE318172B (en)
US2977283A (en) Therapeutic intravenous fat compositions
Lough et al. The lipids of human pancreas with special reference to the presence of fatty acid methyl esters
GB934554A (en) Methods of obtaining substantially stable concentrated extracts of red vine (vitis vinifera) and the extracts resulting therefrom
Ong et al. Incorporation and metabolic conversion of erucic acid in various tissues of the rat in short term experiments
Allison et al. Further studies on the anti-estrogenic activity of yellow pine needles
Strating et al. The staling of beer
KR20170039129A (en) Coix seed oil comprising 16 glycerides, formulation and application thereof
US3042706A (en) Process for purifying pyrethrum extracts
Nazir et al. Determination of ubiquinone and tocopherol in some tissues of shark (Carcharias ellioti day)
Wik et al. Fractionation of soybean phosphatides with isopropyl alcohol
Kokatnur et al. A rapid method for the preparation of peroxides from autoxidized methyl esters of fatty acids
ES8504655A1 (en) Removal of insaponifiable water-insoluble impurities from mixture of cyclohexanone and cyclohexanol
Warren et al. Lipid composition of hexane and supercritical carbon dioxide reduced cholesterol dried egg yolk
GB697007A (en) Improvements relating to the recovery of unsaponifiables from concentrates containing unsaponifiables admixed with saponified fatty materials
SE318368B (en)
GB475070A (en) An improved method for the purification of animal and vegetable oils, fats, waxes, and the therapeutic concentrates obtained therefrom